NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02987777 Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer Status COMPLETED Phase N/A
NCT02943811 Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer Status COMPLETED Phase N/A
NCT02922764 A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer Status COMPLETED Phase PHASE1
NCT02912767 Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer Status COMPLETED Phase N/A
NCT02907073 Positron Emission Tomography (PET) Imaging Studies With NIS Reporter Status TERMINATED Phase PHASE1/PHASE2
NCT02834988 Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer Status COMPLETED Phase N/A
NCT02774395 Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine Status COMPLETED Phase N/A
NCT02767362 A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium Status COMPLETED Phase EARLY_PHASE1
NCT02765698 Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer Status TERMINATED Phase N/A
NCT02744898 A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus Status COMPLETED Phase PHASE2
NCT02730429 Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02730416 Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02725489 Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers Status COMPLETED Phase PHASE2
NCT02690766 Translating Healthy Lifestyle Interventions for Cancer Survivors Status COMPLETED Phase NA
NCT02684318 Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2